Medtentia CEO to Present at the Nordic-American Life Science Investment and Partnering Conference 11.11.2020
FDA grants Breakthrough Device designation to CathHELIX®, Medtentia’s catheter-based mitral valve repair device 25.9.2019
Clinical Study Results Reveal Improved Heart Condition with Medtentia Annuloplasty Ring (MAR) 17.10.2016
Data Collection Completed for the Clinical Study Evaluating Medtentia Annuloplasty Ring Safety and Performance 22.8.2016
Medtentia Helix Ring for Mitral Valve Repair Continues to Achieve All Objectives in Approval Study 31.7.2013